Walleye Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,800
Closed -$688K 5646
2022
Q3
$688K Buy
2,800
+1,600
+133% +$432K ﹤0.01% 2612
2022
Q2
$297K Buy
+1,200
New +$324K ﹤0.01% 3388
2022
Q1
Sell
-200
Closed -$72K 6138
2021
Q4
$72K Sell
200
-600
-75% -$203K ﹤0.01% 4527
2021
Q3
$260K Buy
800
+200
+33% +$67.8K ﹤0.01% 3602
2021
Q2
$187K Sell
600
-1,600
-73% -$491K ﹤0.01% 3984
2021
Q1
$701K Sell
2,200
-4,700
-68% -$1.5M ﹤0.01% 2275
2020
Q4
$2.24M Sell
6,900
-1,300
-16% -$360K 0.01% 1305
2020
Q3
$2.27M Buy
8,200
+1,600
+24% +$461K 0.01% 1036
2020
Q2
$1.59M Sell
6,600
-600
-8% -$120K 0.01% 1281
2020
Q1
$1.04M Sell
7,200
-3,900
-35% -$647K 0.01% 1271
2019
Q4
$1.89M Buy
11,100
+700
+7% +$130K 0.01% 1272
2019
Q3
$1.85M Sell
10,400
-6,100
-37% -$1.32M 0.02% 1118
2019
Q2
$4.3M Buy
16,500
+5,700
+53% +$1.51M 0.04% 541
2019
Q1
$3.08M Buy
10,800
+1,600
+17% +$532K 0.02% 772
2018
Q4
$2.99M Buy
9,200
+6,200
+207% +$2.15M 0.02% 772
2018
Q3
$1.35M Sell
3,000
-300
-9% -$118K 0.01% 1750
2018
Q2
$1.35M Buy
3,300
+2,000
+154% +$725K 0.01% 1763
2018
Q1
$378K Buy
+1,300
New +$329K ﹤0.01% 2939
2017
Q4
Sell
-300
Closed -$51 4737
2017
Q3
$51 Sell
300
-100
-25% -$15.1K ﹤0.01% 3800
2017
Q2
$56 Sell
400
-1,900
-83% -$255K ﹤0.01% 3839
2017
Q1
$290 Sell
2,300
-1,200
-34% -$139K ﹤0.01% 2660
2016
Q4
$395K Buy
3,500
+2,500
+250% +$290K ﹤0.01% 2274
2016
Q3
$129K Buy
+1,000
New +$120K ﹤0.01% 3103

Other funds holding ABMD

Walleye Trading's ABMD Position: Q3 2022 in Review

Walleye Trading sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 2,925 shares — an estimated $790K sold.

Walleye Trading first reported a position in ABMD in Q3 2015 and held it in 10 quarters. The position peaked at $6.63M in Q3 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Walleye Trading reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 2,925 Abiomed Inc shares in Q3 2022, an estimated $790K.
  • Walleye Trading first reported a position in Abiomed Inc in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Abiomed Inc position peaked at $6.63M in Q3 2018.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.